Lothar Krinke

Interface Associates, Inc. manufactures medical balloons and balloon catheter systems. It offers balloon design and development, contract manufacturing, extruded balloon tubing, custom medical extrusion and balloon catheter manufacturing and testing equipment. The firm also provides ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. The company was founded by Joseph Stupecky in 1995 and is headquartered in Laguna Niguel, CA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Fondazione Torino Wireless operates as a funding institution. The firm focuses on international networking and information and communications technology. The company was founded in 2000 and is headquatered in Torino, Italy.

Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA.

Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris.

Court Square Capital Partners LP (Court Square Capital Partners) is a private equity firm founded in 1968. The firm is headquartered in New York.

Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy.

Telegraph Hill Partners Management Co. LLC (Telegraph Hill Partners) is a venture capital firm founded in 2001 by Robert G. Shepler, Thomas A. Raffin and Deval A. Lashkari. The firm is headquartered in San Francisco, California.

CECP Advisors (CECP-UK) is the Great Britain-based venture capital subsidiary of global private equity investment group Carlyle Group LLC, ultimately held by the Carlyle Group LP (NASDAQ: CG) in the US. The group has additional offices throughout Europe in Barcelona, Frankfurt, Luxembourg, Milan, Munich, Paris, Stockholm and Warsaw. Formerly known as CECP Investment Advisors Ltd., the firm was established in 1997 and is based in London. They cooperate closely with Carlyle offices in Paris, Munich, Milan and Barcelona, sub-advising private equity funds for the parent group. They manage the Carlyle Europe Partners series of buyout funds, as well as venture capital funds, all domiciled in Luxembourg. Their international clientele includes public pension funds and agencies, financial institutions, high-net worth individuals and corporate pension schemes.

EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.

Antabio SAS operates as a biopharmaceutical company which develops drugs for the treatment and prevention of antibiotic-resistant bacterial infections. The firm focuses bacterial disease research, drug design, antibiotic combination testing, and in vitro technology development operations. The company was founded by Marc Lemonnier and Aymeric Dugray on October 15, 2009 and is headquartered in Labege, France.

Rehab Technologies LLC is a medical device company. The private company is based in Huntsville, AL.

Prestiamoci SpA provides lending services. It owns the brand Prestiamoci, an online platform which allows the processing of consumer loan applications. The company was founded by Daniele Loro in 2008 and is headquartered in Milan, Italy.

Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France.

Cardiovascular Lab SpA provides health care services. The firm is a bridge between great ideas from physicians and international capital. The company was founded in 2016 and is headquartered in Turin, Italy.

Betaglue Technologies SpA is a holding company, which engages in the provision of medical technology and oncology research services. The company was founded by Francesco Izzo and is headquartered in Naples, Italy.

Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy.

TrakCel Ltd. delivers a suite of integrated technologies to orchestrate the cell therapy supply chain for autologous and allogeneic therapies. The firm serves to medical centers, distribution and logistics clients, manufacturers, and therapy owners and trial sponsors/license holders. The company was founded in 2012 and is headquartered in Cardiff, the United Kingdom.

Emerging Therapy Solutions, Inc. operates predictive intelligence platform which outsourced management of cell and gene therapy treatments for health care payers. It offers pipeline analytics, medical services, contract placement, claims administration, and reporting. The company was founded by Dave J. McLean and is headquartered in Bloomington, MN.

AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018.

Part of Dompe Holdings SRL, Movendo Technology Srl is an Italian company that develops and commercializes robotic and digital rehabilitation solutions for objective, functional assessments and effective treatments. The company is based in Genoa, Italy, with subsidiaries in other locations. Movendo's flagship product, Hunova©, is one of the most versatile robotic assistive devices available, improving orthopedic rehabilitation, the management of neurological and chronic conditions, active aging, and athletic performance. The team clinico of Movendo Technology is active in the collection and analysis of data for the creation of literature and scientific evidence. Movendo Technology is a leading company in the field of rehabilitation technologies. The company was founded by Simone Ungaro, who has been the CEO since incorporation.

THRON SpA specializes in enterprise software solutions. It develops mobile applications for digital file management. The company was founded by Nicola Meneghello and Dario de Agostini in 2000 and is headquartered in Piazzola sul Brenta, Italy.